본문 바로가기
bar_progress

Text Size

Close

Effectiveness UP and Mortality DOWN when Combined with Remdesivir!!

Those who applied for hit the upper limit in just one day! Achieved 31% profit!

Congratulations to everyone who applied for the free trial. ^^


※ For those who missed the “COVID-19 treatment,” don’t worry. We are launching again in full force.

※ Finally starting. PARKUS (065690) follow-up stock hits the upper limit on Tuesday. ※


▶▶ Starting big with the ‘upper limit’ on September 1, the Tocilizumab COVID-19 treatment! ‘ㅇㅇㅇㅇㅇ’ related stock! ▶ Apply for free trial ◀


Research shows that Remdesivir and Tocilizumab could be potential treatments for the novel coronavirus infection!!

This combination therapy is attracting industry attention as a recent paper announced it is safer than the Remdesivir and Dexamethasone combination therapy recognized by the Central Clinical Committee for Emerging Infectious Diseases!!


▶▶ Heading straight ‘up’ on Tuesday. Moving fast, Tocilizumab COVID-19 treatment! Related beneficiary stocks! Don’t miss out [Apply now for ‘Tocilizumab COVID-19 treatment’ related stocks]


“I applied and bought small amounts every day for 3 days, and was amazed to see upper limit profits every day. It’s really incredible how this is possible. It’s been about 3 months since I paid the membership fee and received VIP service, and already 30 million KRW has accumulated in my account. Thank you so much again. Ah! I am actively recommending it to my acquaintances as well.”

(VIP office worker member Yoojin Lee, 41 years old)


Now think of this as your last chance. If you miss this opportunity, you have to give up.

Exactly on “September 1,” it will explode! Don’t miss out and regret it, buy at least 1 million KRW!


▶▶ “September 1 upper limit” offered only until today and then closed. [Receive ‘Tocilizumab COVID-19 treatment’ related stocks!] ▶ Receive stocks ◀


[AI recent upper limit hits]

*20.08.28 PARKUS (065690) upper limit hit!

*20.08.27 Bodytech Med (206640) upper limit hit!

*20.08.26 Telcon RF Pharma (200230) upper limit hit!

*20.08.25 Woori Bio (082850) upper limit hit!

*20.08.24 Jinwon Life Science (011000) upper limit hit!

*20.08.21 Exa Inc. (054940) upper limit hit!

*20.08.20 Wooridul Pharma (004720) 3 consecutive upper limit hits!

*20.08.19 Wooridul Pharma (004720) 2 consecutive upper limit hits!

*20.08.18 Wooridul Pharma (004720) upper limit hit!

*20.08.14 KNN (058400) upper limit hit!

*20.08.13 HL Biotech (028300) upper limit hit!

*20.08.12 Ilsin Bio (068330) upper limit hit!

*20.08.11 Korea Biogen (318000) upper limit hit!

*20.08.10 CIS (222080) upper limit hit!

*20.08.07 Seoyeon Top Metal (019770) upper limit hit!

*20.08.06 Hyosung O&B (097870) upper limit hit!

*20.08.05 DA Technology (196490) upper limit hit!

*20.08.04 Kainos Med (284620) upper limit hit!

*20.08.03 Access Bio (950130) upper limit hit!

*20.07.31 BioSmart (038460) upper limit hit!

*20.07.30 Simtek (222800) upper limit hit!

*20.07.29 Bitsro Tech (042370) upper limit hit!


▶▶ Only 10 spots available. “Tuesday upper limit”! ▶ Get it now ◀


※ First-come, first-served 10 spots closed! Both early and late rounds are finished. The hero of the final injury time winning goal ※


[Today’s stocks of interest]

#Daehwa Pharm #Theragen Etex #Isu Abxis #Bukwang Pharm #Aprogen Pharm


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top